Detalles de la búsqueda
1.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012435
2.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137397
3.
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.
Hematol Oncol
; 39(3): 401-408, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33617659
4.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol
; 100(8): 2005-2014, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388860
5.
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
Acta Oncol
; 60(11): 1527-1533, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499575
6.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Ann Hematol
; 99(7): 1525-1530, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474619
7.
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
Hematol Oncol
; 37(3): 296-302, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892724
8.
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
Ann Hematol
; 98(8): 1885-1890, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044260
9.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392461
10.
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy.
Acta Oncol
; 58(6): 888-890, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30848978
11.
SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra".
Clin Lymphoma Myeloma Leuk
; 24(4): 214-223, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151389
12.
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.
Leukemia
; 38(4): 788-795, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388649
13.
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.
Am J Hematol
; 93(7): E159-E161, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633312
14.
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
Acta Haematol
; 140(4): 231-233, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30384359
15.
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
Cancers (Basel)
; 15(16)2023 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627140
16.
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
Ther Adv Hematol
; 14: 20406207231190683, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693118
17.
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.
Acta Oncol
; 56(10): 1331-1333, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28488914
18.
Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Virchows Arch
; 481(6): 975-979, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35879438
19.
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer.
J Clin Med
; 11(7)2022 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407407
20.
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
Cancer Med
; 10(18): 6310-6316, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34464516